APA (7th ed.) Citation

Almeamar, H., Cullen, L., Murphy, D. J., Crowley, R. K., Toumpanakis, C., Welin, S., . . . O'Toole, D. (2022). Real‐world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours. Journal of Neuroendocrinology, 34(6), 1. https://doi.org/10.1111/jne.13138

Chicago Style (17th ed.) Citation

Almeamar, Hussein, Lisa Cullen, David J. Murphy, Rachel K. Crowley, Christos Toumpanakis, Staffan Welin, Donal O'Shea, and Dermot O'Toole. "Real‐world Efficacy of Lutetium Peptide Receptor Radionuclide Therapy in Patients with Neuroendocrine Tumours." Journal of Neuroendocrinology 34, no. 6 (2022): 1. https://doi.org/10.1111/jne.13138.

MLA (9th ed.) Citation

Almeamar, Hussein, et al. "Real‐world Efficacy of Lutetium Peptide Receptor Radionuclide Therapy in Patients with Neuroendocrine Tumours." Journal of Neuroendocrinology, vol. 34, no. 6, 2022, p. 1, https://doi.org/10.1111/jne.13138.